Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
Department of Human Anatomy and Cell Science, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P4, Canada.
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):201-208. doi: 10.31557/APJCP.2021.22.1.201.
MicroRNAs (miRNAs) play an essential role in the susceptibility and development of cancer cells.
Examining the dependency of breast cancer risk with genetic polymorphisms of miR-1307, miR-1269, and miR-3117 in a sample of Iranian women (southeast region).
The case-control study consisted of 520 individuals (260 diagnosed BC patients, 260 healthy individuals). The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was used for genotyping of miR-1307 rs7911488, miR-1269 rs73239138, and miR-3117 (rs4655646 and rs7512692) polymorphisms.
This study provided evidence that miR-1307 rs7911488 polymorphism significantly reduced the risk of BC in heterozygous AG genotype, as well as dominant (AG+GG) genotype and G allele. A significant correlation was found between dominant (AA+AG) genotype, the A allele and protection against BC due to miR-1269 rs73239138 in the sample of study. In contrast, our findings suggested that AG genotype and G allele of miR-3117 rs4655646 polymorphism could increase BC's susceptibility among the southeastern Iranian females. The miR-3117 rs7512692 variant also increased the risk of BC in codominant, dominant and recessive models, as well as the T allele. The possible dependency of miR-1307, miR-1269, and miR-3117 variants with patients' clinicopathological characteristics and BC was also studied. It was concluded that there is a correlation between miR-3117 rs7512692 variant and tumor grade (p=0.031); also, a correlation between miR-1269 rs73239138 variant and progesterone receptor status (p=0.006). The current investigation revealed that miR-1307, miR-1269, and miR-3117 polymorphisms might play a crucial role in the Iranian population's vulnerability to BC.
.
微小 RNA(miRNA)在癌细胞的易感性和发展中起着重要作用。
在伊朗女性(东南部地区)样本中,研究 miR-1307、miR-1269 和 miR-3117 基因多态性与乳腺癌风险的相关性。
病例对照研究共纳入 520 例个体(260 例乳腺癌患者,260 例健康个体)。采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)法检测 miR-1307 rs7911488、miR-1269 rs73239138 和 miR-3117(rs4655646 和 rs7512692)多态性。
本研究表明,miR-1307 rs7911488 多态性在杂合 AG 基因型、显性(AG+GG)基因型和 G 等位基因中显著降低了乳腺癌的发病风险。在研究样本中,miR-1269 rs73239138 的显性(AA+AG)基因型、A 等位基因与对乳腺癌的保护作用之间存在显著相关性。相反,我们的研究结果表明,miR-3117 rs4655646 多态性的 AG 基因型和 G 等位基因可能会增加伊朗东南部女性患乳腺癌的易感性。miR-3117 rs7512692 变体在共显性、显性和隐性模型中以及 T 等位基因也增加了乳腺癌的发病风险。还研究了 miR-1307、miR-1269 和 miR-3117 变体与患者临床病理特征和乳腺癌的相关性。结果表明,miR-3117 rs7512692 变体与肿瘤分级之间存在相关性(p=0.031);miR-1269 rs73239138 变体与孕激素受体状态之间也存在相关性(p=0.006)。本研究表明,miR-1307、miR-1269 和 miR-3117 多态性可能在伊朗人群易患乳腺癌方面发挥着重要作用。